YY6-52835-58014 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-26
Dose 1 — Pfizer-BioNTech
2021-04-16
Registered in v-safe
2021-04-16
Dose 2 — Pfizer-BioNTech
2021-04-16
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-17
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-04-17
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-04-18
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea — Feeling: Fair · Muscle or body aches

Free text: Short of breath

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-26	Pfizer-BioNTech
2	2021-04-16	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-04-17	priority 2/3

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-18

Systemic reaction (other): Short of breath

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Dyspnoea	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release